What happened
Choong ANG Vaccine Laboratory reported separate results for FY2025: revenue of US$33.4M (+7.6% year on year), operating profit of US$4.41M (+12.5% year on year) and net income of US$4.19M (−10.1% year on year).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$33.4M |
|---|---|
| Revenue vs a year earlier | +7.6% |
| Operating profit | US$4.41M |
| Net income | US$4.19M |
| Period | FY2025 (separate) |
| Filed | 2026-02-06, Change of less than 30% in revenue or profit/loss structure (15% for large companies) (voluntary) |
| Source | DART rcept 20260206901436 → open original filing |
Source: DART. Information only, not investment advice.